CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net income (loss)	$ 77,025	$ 65,535
Adjustments to reconcile net income (loss) to cash flows from operating activities:
Depreciation	143,633	120,066
Amortization (includes amortization of deferred financing costs and discounts of $6,100 and $4,332 for the three months ended March 31, 2024 and 2023, respectively)	72,022	66,360
Revenue reduction associated with amortization of customer inducements and above- and below-market leases	1,321	1,760
Stock-based compensation expense	14,039	12,509
Provision (benefit) for deferred income taxes	1,125	4,183
Loss (gain) on disposal/write-down of property, plant and equipment, net	389	(13,061)
Foreign currency transactions and other, net	(5,091)	34,435
(Increase) decrease in assets	(29,738)	(33,530)
(Decrease) increase in liabilities	(144,687)	(129,449)
Cash Flows from Operating Activities	130,038	128,808
Cash Flows from Investing Activities:
Capital expenditures	(381,145)	(265,906)
Cash paid for acquisitions, net of cash acquired	(122,479)	(1,094)
Customer inducements	(2,286)	(1,357)
Contract costs	(25,304)	(24,014)
Investments in joint ventures and other investments	0	(15,830)
Proceeds from sales of property and equipment and other, net	5,605	35,658
Cash Flows from Investing Activities	(525,609)	(272,543)
Cash Flows from Financing Activities:
Repayment of revolving credit facility, term loan facilities and other debt	(1,730,252)	(4,649,926)
Proceeds from revolving credit facility, term loan facilities and other debt	2,479,378	5,008,631
Equity distribution to noncontrolling interests	(499)	(1,019)
Parent cash dividends	(198,013)	(186,514)
Payment of deferred purchase obligation	(158,677)	0
Net (payments) proceeds associated with employee stock-based awards	(29,498)	(21,271)
Other, net	(340)	0
Cash Flows from Financing Activities	362,099	149,901
Effect of Exchange Rates on Cash and Cash Equivalents	2,338	(1,521)
(Decrease) increase in Cash and Cash Equivalents	(31,134)	4,645
Cash and Cash Equivalents, Beginning of Period	222,789	141,797
Cash and Cash Equivalents, End of Period	191,655	146,442
Supplemental Information:
Cash Paid for Interest	274,796	204,902
Cash Paid for Income Taxes, Net	18,613	18,629
Non-Cash Investing and Financing Activities:
Financing Leases and Other	38,082	20,194
Accrued Capital Expenditures	210,255	207,425
Deferred Purchase Obligations and Other Deferred Payments	133,713	197,222
Dividends Payable	$ 198,875	$ 191,030